KCS Wealth Advisory’s Zimmer Biomet ZBH Stock Holding History

KCS Wealth Advisory’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-453	Closed	-$60.4K	–	422
2019 Q3	$60.4K	Buy	+453	New	+$58.5K	0.04%	226

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

KCS Wealth Advisory's ZBH Position: Q4 2019 in Review

KCS Wealth Advisory sold out of Zimmer Biomet (ZBH) in Q4 2019, closing a stake of 453 shares — an estimated $60.4K sold.

KCS Wealth Advisory first reported a position in ZBH in Q3 2019 and held it in 1 quarter. The position peaked at $60.4K in Q3 2019. 989 funds tracked by Wall St. Rank hold ZBH as of Q4 2019.

KCS Wealth Advisory reported no remaining Zimmer Biomet position as of Q4 2019 after selling out during the quarter.
KCS Wealth Advisory sold 453 Zimmer Biomet shares in Q4 2019, an estimated $60.4K.
KCS Wealth Advisory first reported a position in Zimmer Biomet in Q3 2019 and held it in 1 quarter.
KCS Wealth Advisory's Zimmer Biomet position peaked at $60.4K in Q3 2019.
989 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2019.

Based on KCS Wealth Advisory's 13F filing for Q4 2019, filed 15 Jan 2020.